Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-09
2010-11-30
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S364400
Reexamination Certificate
active
07842713
ABSTRACT:
The present invention relates to a compound of formula (I):or a pharmaceutically acceptable salt or solvate thereof, wherein:Ring A is (4-12)-membered heterocyclyl;Ring B is a fused benzene ring selected from the group consisting of:Ring A, ring B, ring C, R1, R1a, R2, R3, R4, L2, n, t, w, and z are as defined in the specification. The invention also relates to pharmaceutical compositions comprising the compounds of formula (I) and methods of treating a condition that is mediated by the modulation of glucokinase, the method comprising administering to a mammal an effective amount of a compound of formula (I).
REFERENCES:
patent: 5972936 (1999-10-01), Dyke et al.
patent: 6066657 (2000-05-01), Dyke et al.
patent: 6117874 (2000-09-01), Dombroski et al.
patent: 6121274 (2000-09-01), Ulrich et al.
patent: 6133286 (2000-10-01), Dombroski et al.
patent: 6211203 (2001-04-01), Amschler
patent: 2004/0013286 (2004-01-01), Viola et al.
patent: 2005/0026969 (2005-02-01), Cheng et al.
patent: 2006/0058353 (2006-03-01), Mckerrecher et al.
patent: 2006/0142269 (2006-06-01), Dykes
patent: 2006/0148888 (2006-07-01), Krauss et al.
patent: 2006/0205751 (2006-09-01), Lee et al.
patent: 2006/0287291 (2006-12-01), Johansson et al.
patent: 0606489 (1993-07-01), None
patent: WO2004046139 (2004-06-01), None
patent: WO2006030031 (2006-03-01), None
patent: WO2006106326 (2006-10-01), None
patent: WO2007043638 (2007-04-01), None
patent: WO2008079787 (2008-07-01), None
English Language Translation (Machine-Generated) of WO 2007/043638.
Janusz, J.M., et al., “New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 3. 7-tert-Butyl-2-,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents: Variations at the 5 Position”, Journal of Medicinal Chemistry, 1998, pp. 3515-3529, vol. 41, American Chemical Society, Washington, US.
Bai Hao
Bailey Simon
Bhumralkar Dilip Ramakant
Bi Feng C.
Guo Fengli
Kispert Jennifer A.
Pfizer Inc
Saeed Kamal A
Shterengarts Samantha L
Wichtowski John A.
LandOfFree
Fused phenyl amido heterocyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused phenyl amido heterocyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused phenyl amido heterocyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4223005